| Literature DB >> 22391478 |
V Anik Sahni1, Michelle S Hirsch, Cheryl A Sadow, Stuart G Silverman.
Abstract
This article describes the features on sonography, computed tomography (CT) and magnetic resonance imaging (MRI) of mucinous tubular and spindle cell carcinoma of the kidney. Six pathologically proven cases of mucinous tubular and spindle cell carcinoma of the kidney were identified (5 females, 1 male); all patients underwent preoperative imaging. The mean age of the patients was 58.5 years. Thirteen imaging studies were available for review: 2 sonograms, 1 unenhanced CT scan, 5 contrast-enhanced CT scans, 1 unenhanced magnetic resonance imaging (MRI) examination, and 4 contrast-enhanced MRI examinations. Two abdominal radiologists evaluated all images retrospectively on a PACS workstation using a standardized data collection sheet until consensus was reached. All mucinous tubular and spindle cell carcinomas presented as well-marginated, small (mean 2.6 cm, range 1.9-3.2 cm) predominantly solid masses. No intratumoral fat or calcification was identified. Unenhanced CT and MRI appearances were variable as was the degree of enhancement following intravenous contrast material administration. There was no evidence of perinephric extension, renal vein involvement or metastatic disease in any of the cases. The radiological appearance of mucinous tubular and spindle cell carcinoma is diverse and therefore indistinguishable from the more common subtypes of renal cell carcinoma.Entities:
Mesh:
Year: 2012 PMID: 22391478 PMCID: PMC3335336 DOI: 10.1102/1470-7330.2012.0008
Source DB: PubMed Journal: Cancer Imaging ISSN: 1470-7330 Impact factor: 3.909
Figure 1A 65-year-old woman with mucinous tubular and spindle cell carcinoma of right kidney. (a) Sagittal sonogram shows a well-marginated hypoechoic mass (arrow). (b,c) Axial CT scans during unenhanced (b) and nephrographic (c) phases demonstrate a 1.9-cm intraparenchymal enhancing mass (arrows). (d) An 18-gauge biopsy specimen demonstrates oncocytic epithelioid cells with a tubular architecture, associated with a prominent myxoid matrix.
Figure 2A 67-year-old man with mucinous tubular and spindle cell carcinoma of left kidney. (a) Sagittal sonogram shows a well-marginated hypoechoic mass (arrow) arising from the lower pole. (b) Axial CT scans during the unenhanced phase demonstrates a 3.2-cm exophytic hyperdense mass (short arrow), and a nearby hyperdense cyst (long arrow). (c) Coronal T2-weighted MR image demonstrates T2-hypointensity of the mass (short arrow). The adjacent cyst (long arrow) is also T2-hypointense in keeping with hemorrhage. (d,e) Coronal T1-weighted fat-suppressed sequence in unenhanced (d) and nephrographic (e) phases shows enhancement of the mass (short arrow) and no enhancement of the cyst (long arrow). (f) An 18-gauge biopsy specimen demonstrates a mixture of epithelioid and bland spindle cells associated with a desmoplastic matrix; confirmatory cytogenetics helped make the correct diagnosis in this case.
Imaging features of mucinous tubular and spindle cell carcinoma
| Variable | Patient | |||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| Age (years) | 65 | 47 | 38 | 67 | 65 | 69 |
| Gender | Female | Female | Female | Male | Female | Female |
| Maximum size (cm) | 1.9 | 2.8 | 2.4 | 3.2 | 2.1 | 3.1 |
| Side | Right | Left | Right | Left | Left | Left |
| Predominant location | Parenchyma | Parenchyma | Parenchyma | Exophytic | Parenchyma | Parenchyma |
| Cystic component | No | No | Yes | No | No | No |
| Sonographic echogenicity relative to renal parenchyma | Hypoechoic | N/A | N/A | Hypoechoic | N/A | N/A |
| Unenhanced CT density relative to renal parenchyma | Isodense | N/A | Isodense | Hyperdense | Hyperdense | Isodense |
| CT enhancement in nephrographic phase | 76 HU | N/A | 86 HU | 13 HU | 34 HU | N/A |
| T1 signal relative to renal parenchyma | Isointense | N/A | Isointense | Isointense | Isointense | Isointense |
| T2 signal relative to renal parenchyma | Isointense | N/A | Hyperintense | Hypointense | Hyperintense | Hypointense |
| MRI enhancement in nephrographic phase (%) | N/A | N/A | 107 | 63 | 151 | 116 |
CT enhancement, attenuation of mass after intravenous contrast material administration minus unenhanced attenuation; MR enhancement, signal intensity of mass after intravenous contrast administration minus unenhanced signal intensity divided by unenhanced signal intensity; N/A, not available.